patients instead of the 5 mm instruments is common due to the shorter wrist lengths. We hypothesized that the use of 5 mm instruments for RAL pyeloplasty in infants with smaller working spaces will not affect the perioperative parameters and surgical outcomes in comparison to older children with larger working spaces.
INTRODUCTION AND OBJECTIVES: MRI targeted biopsy has changed the evaluation paradigm of patients with elevated PSA. However, in patients without a rectum, the fusion platforms to target suspicious lesions on MRI cannot be utilized due to inability to use transrectal ultrasound. In-bore MRI guided biopsy is a potential alternative for targeting specific lesions in these patients. This report outlines the techniques used in a series of five patients undergoing in-bore MRI guided prostate biopsy using registration with the Visualaseâ (Medtronic) MRI guided laser ablation platform.
METHODS: Patients without rectum with presence of suspicious lesions on prostate mpMRI were scheduled for biopsy in the MRI suite. Patients were placed under general anesthesia and prepped and draped on the MRI table in the frog-leg position. The biopsy grid was positioned to be flush with the perineum. T2W MR images of the prostate were obtained, transferred to the Visualase platform, and registered to the fiducials using the Visualase system. Serial T1W MR images were used to identify the location and depth of the lesion and then to confirm the location of the biopsy needles. A total of 2-8 cores were obtained from each patient. After completion of the procedure, patients were transferred to the recovery area in stable condition.
RESULTS: Four patients with suspicion of prostate cancer on prostate mpMRI and surgical absence of rectum underwent prostate biopsy by above technique. The median age was 72 (58-77) years and median PSA was 4.28ng/ml (3.6-6.73 
INTRODUCTION AND OBJECTIVES:
Intraoperative identification of nerves is essential in various surgical scenarios, where nerve injury can be inadvertent and cause loss of function. We compared the diagnostic efficacy of intravenous (IV) vs. topical administration of the fluorophore GE3126 to identify nerves in a surgical model. METHODS: Surgical models were created using Yorkshire pigs. Under general anesthesia, a laparotomy was performed and the retroperitoneum exposed. GE3126 was administered using an IV or topical route. Fluorescence was recorded using open and laparoscopic imaging systems. A retroperitoneal dissection was performed to harvest distinct fluorescent structures resembling nerves. Pigs were euthanized at the end of the procedure. Pathologic analysis of harvested tissues included microscopy and staining with hematoxylin and eosin (H&E) and Luxol fast blue. Fisher 0 s exact test was used to compare the positive predictive value of fluorescence after intravenous vs. topical administration of GE3126.
RESULTS: Specimens were collected from 5 animals after IV administration of GE3126 (dose range, 0.7-10 mg/kg), and from 5 animals after topical administration of GE3126 (dose range, 100-900 mcg) A total of 15 distinct fluorescent structures were harvested after IV injection; 11 were harvested after topical application. The positive predictive value for nerve identification was 11/15 (73%) for the IV route vs. 8/11 (73%) for the topical route (p¼1.0). The average diameter of nerves identified was 560 microns, ranging from 20 to 2,072 microns, with a similar diameter distribution between specimens collected after IV and topical administration.
CONCLUSIONS: Real-time anatomical enhancement of nerves was consistently achieved in a large animal model using the fluorophore GE3126, with similar diagnostic efficacy whether administered using an IV or topical route. Research in human subjects is warranted.
